These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 26176340)
1. Impact of preoperative evaluation of tumour grade by core needle biopsy on clinical risk assessment and patient selection for adjuvant systemic treatment in breast cancer. Waaijer L; Willems SM; Verkooijen HM; Buck DB; van der Pol CC; van Diest PJ; Witkamp AJ Br J Surg; 2015 Aug; 102(9):1048-55. PubMed ID: 26176340 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen. Knuttel FM; Menezes GL; van Diest PJ; Witkamp AJ; van den Bosch MA; Verkooijen HM Br J Surg; 2016 May; 103(6):644-655. PubMed ID: 26990850 [TBL] [Abstract][Full Text] [Related]
3. Assessment of pathologic prognostic factors in breast core needle biopsies. Sharifi S; Peterson MK; Baum JK; Raza S; Schnitt SJ Mod Pathol; 1999 Oct; 12(10):941-5. PubMed ID: 10530557 [TBL] [Abstract][Full Text] [Related]
4. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854 [TBL] [Abstract][Full Text] [Related]
6. Invasive ductal carcinoma of the breast: correlation between tumor grade determined by ultrasound-guided core biopsy and surgical pathology. Zheng J; Alsaadi T; Blaichman J; Xie X; Omeroglu A; Meterissian S; Mesurolle B AJR Am J Roentgenol; 2013 Jan; 200(1):W71-4. PubMed ID: 23255773 [TBL] [Abstract][Full Text] [Related]
7. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy]. Kósa C; Garami Z; Dinya T; Fülöp B Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391 [TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer. Park AY; Gweon HM; Son EJ; Yoo M; Kim JA; Youk JH Eur J Radiol; 2014 Apr; 83(4):654-9. PubMed ID: 24534119 [TBL] [Abstract][Full Text] [Related]
9. The use of sentinel lymph node biopsy in ductal carcinoma in situ. Schneider C; Trocha S; McKinley B; Shaw J; Bielby S; Blackhurst D; Jones Y; Cornett W Am Surg; 2010 Sep; 76(9):943-6. PubMed ID: 20836339 [TBL] [Abstract][Full Text] [Related]
10. Papillary lesions on core breast biopsy: excisional biopsy for all patients? McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ Am Surg; 2013 Dec; 79(12):1238-42. PubMed ID: 24351348 [TBL] [Abstract][Full Text] [Related]
11. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955 [TBL] [Abstract][Full Text] [Related]
12. Grading of breast cancer on needle core biopsy: does a reduction in mitotic count threshold improve agreement with grade on excised specimens? Dhaliwal CA; Graham C; Loane J J Clin Pathol; 2014 Dec; 67(12):1106-8. PubMed ID: 25185140 [TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]. Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260 [TBL] [Abstract][Full Text] [Related]
14. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies. Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487 [TBL] [Abstract][Full Text] [Related]
15. Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour. Lorgis V; Algros MP; Villanueva C; Chaigneau L; Thierry-Vuillemin A; Nguyen T; Demarchi M; Bazan F; Sautiere JL; Maisonnette-Lescot Y; Ringenbach F; Bontemps P; Pivot X Breast; 2011 Jun; 20(3):284-7. PubMed ID: 21288720 [TBL] [Abstract][Full Text] [Related]
16. Histologic grading at breast core needle biopsy: comparison with results from the excised breast specimen. Monticciolo DL Breast J; 2005; 11(1):9-14. PubMed ID: 15647072 [TBL] [Abstract][Full Text] [Related]
17. Histological grade of invasive carcinoma of the breast assessed on needle core biopsy - modifications to mitotic count assessment to improve agreement with surgical specimens. O'Shea AM; Rakha EA; Hodi Z; Ellis IO; Lee AH Histopathology; 2011 Sep; 59(3):543-8. PubMed ID: 21906126 [TBL] [Abstract][Full Text] [Related]
18. Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer. Munch-Petersen HD; Rasmussen BB; Balslev E APMIS; 2014 Sep; 122(9):750-4. PubMed ID: 24372587 [TBL] [Abstract][Full Text] [Related]
19. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Brennan ME; Turner RM; Ciatto S; Marinovich ML; French JR; Macaskill P; Houssami N Radiology; 2011 Jul; 260(1):119-28. PubMed ID: 21493791 [TBL] [Abstract][Full Text] [Related]
20. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS Breast J; 2007; 13(3):251-7. PubMed ID: 17461899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]